A healthy, growing manufacturing industry is essential for good, middle-class jobs, for broadly shared prosperity in the US, and for long-term economic growth. Manufacturing is essential for national security, health security, and a robust, resilient supply of many essential and non-essential goods.
The US must make the US dollar competitive again, rebalance trade, and support US manufacturing with effective Buy American policies to relaunch manufacturing growth. We must use tariff policies where required against foreign predation, dumping, IP theft, and other anti competitive policies of foreign governments. We must use targeted industrial policies when necessary to support industries deemed essential for national security or economic security.
Trade structured to support production raises productivity, and rising productivity raises the incomes that fund consumption durably, out of earnings instead of borrowing. That is the only durable answer to the cost-of-living crisis: paychecks that can carry the price of housing, healthcare, and childcare.
For years, the most critical link in our drug supply chain — the upstream chemistry — has been invisible to our own regulators. A medicine finished in Europe is not necessarily a European medicine, and this rule finally begins to expose that fiction.
A new joint white paper finds that aluminum extrusion — the most capital-intensive step in frame production — must occur in the United States for solar module frames to qualify for the Section 45Y/48E domestic content bonus credit.
Before USTR borrows the tin cartel’s playbook, it should look to the American tradition of minimum import pricing — and beware the foreign imitations that ended in ruin.
Years ago, CPA warned that China was using American clean-energy tax credits to capture our solar industry — and we led the fight to slam that door shut.
Sen. Kirsten Gillibrand (D-NY) has become one of the Democratic Party’s leading voices raising concerns about the pharmaceutical industry’s growing ties to China.
